Guchen Yang - Concepedia

Author

Guchen Yang

Bristol-Myers Squibb (United States)

Also Known As

, Guchen Yang, Yang, Guchen

Publications

316

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Bristol-Myers Squibb (Sweden)

About

Guchen Yang is an author at Bristol-Myers Squibb (United States) specializing in pharmacotherapy, drug discovery, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	143
2	Natural Sciences	2	2	70
3	Chemical Biology	2	2	70
4	Immunology	2	2	73
5	Biochemistry	1	1	57

Guchen Yang

Publications

312

Citations

H-Index

Page 1

	Year	Citations
Phosphodiesterase 7A-Deficient Mice Have Functional T Cells Guchen Yang, Kim W. McIntyre, Robert M. Townsend, The Journal of Immunology	2003	97
Rational Design and Synthesis of an Orally Active Indolopyridone as a Novel Conformationally Constrained Cannabinoid Ligand Possessing Antiinflammatory Properties Stephen T. Wrobleski, Ping Chen, John Hynes, Journal of Medicinal Chemistry Combinatorial ChemistryOrally Active IndolopyridonePharmacotherapyBioactive Amide ConformationChemical Biology	2003	57
Discovery of the CCR1 Antagonist, BMS-817399, for the Treatment of Rheumatoid Arthritis Joseph B. Santella, Daniel S. Gardner, John V. Duncia, Journal of Medicinal Chemistry InflammationRheumatologyRheumatoid DisorderCcr1 AntagonistAnti-inflammatory	2014	55
Periodic, Partial Inhibition of IκB Kinase β-Mediated Signaling Yields Therapeutic Benefit in Preclinical Models of Rheumatoid Arthritis Kathleen M. Gillooly, Mark A. Pattoli, Tracy L. Taylor, Journal of Pharmacology and Experimental Therapeutics	2009	26
Extracellular matrix is a source of mitogenically active platelet-derived growth factor Susan L. Field, Levon M. Khachigian, M.J. Sleigh, Journal of Cellular Physiology	1996	19
The discovery of BMS-457, a potent and selective CCR1 antagonist Daniel S. Gardner, Joseph B. Santella, John V. Duncia, Bioorganic & Medicinal Chemistry Letters G Protein-coupled ReceptorMedicineFunctional SelectivityImmunologySelective Ccr1 Antagonist	2013	18
Discovery and Lead Optimization of a Novel Series of CC Chemokine Receptor 1 (CCR1)-Selective Piperidine Antagonists via Parallel Synthesis Cullen L. Cavallaro, Stephanie W. Briceno, Jing Chen, Journal of Medicinal Chemistry	2012	17
Urea based CCR3 antagonists employing a tetrahydro-1,3-oxazin-2-one spacer T. G. Murali Dhar, Guchen Yang, Paul Davies, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBioorganic ChemistryNatural SciencesMedicineMechanism Of Action	2008	13
Novel tricyclic inhibitors of IKK2: Discovery and SAR leading to the identification of 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-7-yl)pyridin-2-yl)methyl)acetamide (BMS-066) Scott H. Watterson, Charles M. Langevine, Katy Van Kirk, Bioorganic & Medicinal Chemistry Letters	2011	10

Page 1